XLV Vs. BME: Total Return Or Income, Which Healthcare Strategy Wins?
The Health Care sector, lagging in recent years, is positioned for mean reversion and potential outperformance in 2026. XLV offers low-cost, passive exposure to large-cap Health Care, with a 1.4-1.8% yield and a 19.94x forward P/E. BME, an actively managed closed-end fund, provides a 7.51% yield, trades at a -5.97% NAV discount, and distributes mainly long-term capital gains.
December Jobs Data Put Focus on These Sector ETFs & Stocks
December jobs data highlight sector shifts as healthcare and restaurants add jobs, while retail lags. ETFs XLV, EATZ in focus.
6 Major Investment Themes Shaping 2026
The market looks set to maintain momentum into the New Year with investment in AI infrastructure continuing. But several other sectors are positioned for growth as well.
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)?
Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the State Street Health Care Select Sector SPDR ETF ETF (XLV), a passively managed exchange traded fund launched on December 16, 1998.
XLV: The Simple Case For Overweighting U.S. Health Care
The H ealth Care Select Sector SPDR is comprised of all the Health Care stocks inside the S&P 500 Index. Its expense ratio is only 0.08% and XLV has $41.2B in AUM. The simple case for overweighting U.S. Health Care is that XLV currently features a unique combination of a low beta, moderate growth, and excellent momentum and sentiment. XLV also offers terrific growth-at-a-reasonable-price features, but only on a forward basis. A GARP analysis based on historical metrics highlights an interesting divide worth watching.
Best-Performing ETFs of November
November muted for markets, but ETFs like SPYM, BWET, WNTR, LITP and OZEM stand out.
XLV: Lower Interest Rates And A Positive Growth Outlook Will Pave The Way
The Fed has begun to reduce interest rates in the U.S. This decision will incentivize the deployment of funding in the healthcare industry. The top holdings of XLV are profitable firms, with a median expected growth rate of 6.53% in their revenues. The U.S. legislation that mandates drugmakers to lower the selling price of their medicine in the country will only be applied to Medicaid beneficiaries, which has a limited effect.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Health Care Select Sector SPDR ETF (XLV) is a passively managed exchange traded fund launched on December 16, 1998.
XLV: Market Overreaction Could Drive Double Digit Shareholder Yield
Healthcare sector trades at a historic discount due to patent expirations, managed care uncertainty, and drug pricing proposals, but pessimism is overdone. Key catalysts include potential M&A activity and likely continued NIH funding, both of which could drive sector recovery and rerating. XLV stands out among healthcare ETFs for its liquidity, high concentration in undervalued leaders, low turnover, and minimal fees.
Is This the Right Time to Consider Healthcare ETFs?
XLV lags SPY by double digits over the past year, but Buffett's UNH bet, hedge fund buys and AI optimism hint at a healthcare revival.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Health Care Select Sector SPDR ETF (XLV) is a passively managed exchange traded fund launched on December 16, 1998.
Healthcare: Winning Sector ETF Amid Soft U.S. July Jobs Report
Healthcare led July job gains with 55,000 new positions, as most other U.S. sectors showed little to no growth. Tap ETFs like XLV and VHT.
